Quantification of CB1 immunoreactivity revealed that receptor expression is notably enriched in the dysplastic areas of FCD Type II when compared with control brain tissue, but not in FCD Type I (Figures 1A,C). This evidence concerns the gene CNR1 and fleck corneal dystrophy.